Clinical trial
Interest of Molecular Analysis of Cerebral Thrombi in Determining the Prognosis and Etiology of Cerebral Infarction
NCT05658835 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest of Molecular Analysis of Cerebral Thrombi in Determining the Prognosis and Etiology of Cerebral Infarction
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 8, 2023
- Completion date
- February 28, 2025
- Enrollment
- 311 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.